United Kingdom Archives

Interview 3 Jul 2019

Meet the First Company in the Brand New Field of Epitranscriptomics

A whole new therapeutic area is taking medical research by storm. In Cambridge, UK, the company Storm Therapeutics is leading the development of the first treatments to target a new layer of genetic information encoded in the RNA. The term ‘epitranscriptomics’ did not exist a decade ago. It was coined in 2012, when scientists started […]

July 3, 2019 - 5 minutesmins - By Clara Rodríguez Fernández

Startup Scout 28 Jun 2019

This Biotech Makes Dyes from Agricultural Waste Using Microbes

Welcome to Norwich, UK, where Colorifix converts agricultural waste products into dyes using microbes, reducing the water and energy required to produce the dyes. Mission: To make textile dyes more sustainable by replacing chemical methods with microbial fermentation. Dyes are an essential part of the textile and fashion industries. The majority of dyes today are […]

June 28, 2019 - 3 minutesmins - By Jonathan Smith

atelerix cell therapy newcastle freeze encapsulation

News and Trends 21 Jun 2019

This Biotech Transports Cell Therapies Without Needing a Freezer

The biotech Atelerix, based in Newcastle, UK, can transport cell therapies between different locations with less cost and risk than current methods by encapsulating the cells in a specialized gel. Mission: To eliminate the need for costly cold storage in the cell transport process by preserving cells in a gel. This could save further costs […]

June 21, 2019 - 3 minutesmins - By Jonathan Smith

Best in Biotech 10 Jun 2019

The 10 Biotech Companies in London to Keep an Eye on in 2019

Which biotechs will be stealing the show this year? These are some of the most exciting biotech companies in London right now. London is undoubtedly one of the biggest hubs for biotech companies in the U.K. and in Europe. The British capital was the one that received the most life sciences investment in Europe in […]

June 10, 2019 - 5 minutesmins - By Clara Rodríguez Fernández

News and Trends 20 May 2019

UK Immune Cell Therapy Biotech Founded with €40M Series A

Quell Therapeutics, a London-based biotech developing immune cell therapies to target transplant rejection and autoimmune and inflammatory diseases, launched today with €40M series A funding. UK life sciences trust Syncona is the lead investor, with a €38.8M stake in the company. Syncona will own a controlling 69% of the business, reflecting their large initial investment. […]

May 20, 2019 - 2 minutesmins - By Helen Albert

News and Trends 20 May 2019

Update: British RNA Biotech Increases Series A to €34M

Update (20/05/19): Storm Therapeutics has increased its series A financing round by an additional €16M (£14M) to €34M (£30M), which the company plans to use to advance its pipeline of RNA focused drug candidates towards the clinic. Seroba Life Sciences, an Irish VC focusing on new and innovative therapies, is the key new investor. Existing […]

May 20, 2019 - 2 minutesmins - By Helen Albert

dna synthesis synthetic biology cambridge

More News! 16 May 2019

UK Scientists Open Bacterial Genome Up to Making Artificial Proteins

A research group from the University of Cambridge has created bacteria with less complexity in their genome, which could free up DNA code for producing synthetic proteins never before seen in nature. There are lots of redundancies in the DNA code, meaning there is sometimes more than one DNA sequence that can result in the […]

May 16, 2019 - 2 minutesmins - By Jonathan Smith

celixir rnai silencing cancer colon breast

News and Trends 14 May 2019

RNAi Therapy Smashes Solid Tumors in Preclinical Tests

Developed by the UK biotech Celixir, a therapy based on silencing genes with RNA molecules in a process called RNAi has shrunk tumors by 50% in culture. Although there are lots of innovative cancer treatments in the market, such as CAR T-cell therapy for blood cancer, solid tumors remain difficult to tackle. For this reason, […]

May 14, 2019 - 2 minutesmins - By Jonathan Smith

Startup Scout 10 May 2019

This Biotech Destroys Cancer Proteins by Introducing Them to ‘Executioner’ Proteins

Nestled in the biotech hub of Cambridge, UK, is Polyprox. Less than a year old, this company is developing a new class of protein-based drugs that could treat cancer by degrading key proteins in the cancer cell. Mission: Develop drugs that destroy proteins in cancer cells by recruiting executioner proteins, called ligases. Polyprox develops protein […]

May 10, 2019 - 4 minutesmins - By Jonathan Smith

News and Trends 8 May 2019

Schizophrenia Treatments Could be Tested and Personalized Using Patients’ Blood

Scientists at the University of Cambridge have developed a way to screen treatments for schizophrenia on single cells from a patient’s blood sample, which could speed up drug discovery and help to personalize treatments for people with the condition. Around 21 million people worldwide suffer from schizophrenia, and this is likely to get worse with […]

May 8, 2019 - 2 minutesmins - By Jonathan Smith

bees dying university of Cambridge vaccine virus

News and Trends 6 May 2019

Molecules in Bee Jelly Could Protect Whole Nests Against Viruses for Generations

A research team has discovered that honeybees pass molecules of RNA to each other by sharing it in edible jelly, which could lead to vaccines that can stop generations of bees from dying from viral infections. Honeybees don’t just give us honey. As the dominant pollinators of lots of food crops, around a third of […]

May 6, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 1 May 2019

Next-Generation CAR-T Therapy Shows Promise in Child’s Neuroblastoma

Cell Medica’s next-generation CAR-T cell therapy has resulted in ‘extensive tumor regression’ in a child with high-risk neuroblastoma, one of the deadliest types of childhood cancer. Only available to cancer patients for the last couple of years, CAR-T cell therapy has had impressive results in treating patients for whom other available options do […]

May 1, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

United Kingdom

Meet the First Company in the Brand New Field of Epitranscriptomics

This Biotech Makes Dyes from Agricultural Waste Using Microbes

This Biotech Transports Cell Therapies Without Needing a Freezer

The 10 Biotech Companies in London to Keep an Eye on in 2019

UK Immune Cell Therapy Biotech Founded with €40M Series A

Update: British RNA Biotech Increases Series A to €34M

UK Scientists Open Bacterial Genome Up to Making Artificial Proteins

RNAi Therapy Smashes Solid Tumors in Preclinical Tests

This Biotech Destroys Cancer Proteins by Introducing Them to ‘Executioner’ Proteins

Schizophrenia Treatments Could be Tested and Personalized Using Patients’ Blood

Molecules in Bee Jelly Could Protect Whole Nests Against Viruses for Generations

Next-Generation CAR-T Therapy Shows Promise in Child’s Neuroblastoma

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!